Thornton and Ross Revenue and Competitors

Founded in 1922, Thornton & Ross Ltd is one of the largest OTC pharmaceutical manufacturers in the UK and exports to over 80 countries worldwide. We continue to grow our business every year in the UK and International markets by innovation and acquisition. Following the company’s acquisition by the STADA group Thornton & Ross has merged with Genus Pharmaceuticals. From a base in Huddersfield, West Yorkshire, Thornton & Ross develop, manufacture and supply a wide and growing range of branded OTC medicines, dermatological preparations, niche generic medicines and other pharmaceutical, healthcare and hygiene products. Our product portfolio encompasses a large number of well-known OTC brands such as Covonia®, Hedrin®, Care®, Cetraben®, Movelat®, Radian B® and Setlers®, as well as the UK's leading disinfectant Zoflora®. We also own the Flexitol® brand in the UK and Eire. Our values reflect our roots as a family-owned business and we continue to combine the highest professional standards with traditional levels of care. Our approach is to combine good, responsive customer service and quality products, in a working environment that encourages innovation. Thornton & Ross is owned by Frankfurt based STADA Arzneimittel AG STADA is a pan-European pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. With sales of over two billion Euros, STADA affords Thornton & Ross with both research and development support and financial investment. Thornton & Ross has become the Centre of Excellence within the STADA group in order to promote the development of OTC and Dermatology business.